Clinical Features and Outcomes Associated With Parainfluenza Virus-Associated Pneumonia
Researchers found limited clinical variability between PIV serotypes and substantial overlap in presenting signs and symptoms for PIV and other etiologies.
General Pulmonology
Invasive Aspergillosis Superinfection Possible in Symptomatic COVID-19
Critically ill patients hospitalized with COVID-19 — particularly those who develop ARDS — may also experience an opportunistic aspergillosis superinfection.
Clinical Practice Guideline: Treatment of Nontuberculous Mycobacterial Pulmonary Disease
New clinical practice guidelines for the treatment of nontuberculous mycobacterial pulmonary disease were published by leading respiratory medicine and infectious disease societies.
Lifting COVID-19 “Lockdown” Restrictions May Cause Infection Resurgence
Lifting “lockdown” restrictions imposed to reduce the spread of COVID-19 would most likely result in a resurgence of infections.
NIH: Trial Investigating Hydroxychloroquine for COVID-19 Stopped
A National Institutes of Health-led clinical trial evaluating hydroxychloroquine for the treatment of coronavirus disease 2019 (COVID-19) has been halted after a data and safety monitoring board determined that the drug was unlikely to benefit hospitalized patients.
COVID-19 Outcomes in Critically Ill Patients in New York City
In patients admitted to the hospital with COVID-19 in New York City, critical illness is common and associated with high frequency of invasive mechanical ventilation.
Aspiration, Infections Increase Risk for Bronchiectasis in AERD
Risk factors for bronchiectasis in patients with AERD include older age as well as the presence of allergic bronchopulmonary aspergillosis, aspiration, mycobacterial infection, and pneumonia.
Managing Sarcoidosis During COVID-19 Pandemic: An Expert Guidance Statement
In patients with sarcoidosis, COVID-19 can increase the risk for poor outcomes and death, which has resulted in the need for additional guidance on caring for these patients during the pandemic.
Asthma, COPD Inhaler Medication Adherence Trends During COVID-19
Patients with asthma and COPD appear to have increased their adherence to inhaler medications in the wake of the COVID-19 pandemic.
Metagenomic Sequencing Reconfirms Key Role of Gut Microbiome in AS Pathogenesis
Researchers evaluated the microbial characteristics driving ankylosing spondylitis pathogenesis, and they examined the effects of tumor necrosis factor inhibitor therapy on the microbiome.
-
Loading...
-
Loading...
Next post in GI Illness
